Master Class Series

Supported by BridgeBio

Tools to Diagnose and Monitor ATTR-CM

David Ferman, MD, FACC, FHFSA
Spectrum Health
Grand Rapids, MI
Ike Okwuosa, MD
Northwestern Feinberg
School of Medicine
Chicago, IL
David Wolinsky, MD, FACC, MASNC
Cleveland Clinic
Weston, FL
During this discussion, transthyretin amyloidosis specialists will be outlining the diagnostic and prognostic tools that are utilized to help guide treatment decisions for ATTR-CM.

Related Items

Amyloidosis News
Subscribe to Amyloidosis News

Stay up to date with Amyloidosis News by subscribing to receive the free AMN e‑Newsletter.